Parameters influencing the stealthiness of colloidal drug delivery systems
- PMID: 16650890
- DOI: 10.1016/j.biomaterials.2006.03.039
Parameters influencing the stealthiness of colloidal drug delivery systems
Abstract
Over the last few decades, colloidal drug delivery systems (CDDS) such as nano-structures have been developed in order to improve the efficiency and the specificity of drug action. Their small size permits them to be injected intravenously in order to reach target tissues. However, it is known that they can be rapidly removed from blood circulation by the immune system. CDDS are removed via the complement system and via the cells of the mononuclear phagocyte system (MPS), after their recognition by opsonins and/or receptors present at the cell surface. This recognition is dependent on the physicochemical characteristics of the CDDS. In this study, we will focus on parameters influencing the interactions of opsonins and the macrophage plasma membrane with the surface of CDDS, whereby parameters of the polymer coating become necessary to provide good protection.
Similar articles
-
Past and future evolution in colloidal drug delivery systems.Expert Opin Drug Deliv. 2008 Jan;5(1):69-85. doi: 10.1517/17425247.5.1.69. Expert Opin Drug Deliv. 2008. PMID: 18095929 Review.
-
Serum opsonins and liposomes: their interaction and opsonophagocytosis.Crit Rev Ther Drug Carrier Syst. 1992;9(1):39-90. Crit Rev Ther Drug Carrier Syst. 1992. PMID: 1544174 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Stealth properties to improve therapeutic efficacy of drug nanocarriers.J Drug Deliv. 2013;2013:374252. doi: 10.1155/2013/374252. Epub 2013 Mar 7. J Drug Deliv. 2013. PMID: 23533769 Free PMC article.
-
Novel drug delivery systems in pain therapy.Minerva Anestesiol. 2007 Mar;73(3):173-9. Epub 2006 Dec 12. Minerva Anestesiol. 2007. PMID: 17159768 Review.
Cited by
-
Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy.ACS Nano. 2010 Sep 28;4(9):4971-8. doi: 10.1021/nn100560p. ACS Nano. 2010. PMID: 20738118 Free PMC article.
-
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Biomaterials. 2014 Mar;35(9):3027-34. doi: 10.1016/j.biomaterials.2013.12.022. Epub 2014 Jan 2. Biomaterials. 2014. PMID: 24388798 Free PMC article.
-
PEGylated graphene oxide elicits strong immunological responses despite surface passivation.Nat Commun. 2017 Feb 24;8:14537. doi: 10.1038/ncomms14537. Nat Commun. 2017. PMID: 28233871 Free PMC article.
-
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070. Pharmacol Rev. 2016. PMID: 27363439 Free PMC article. Review.
-
Poly(ethylene glycol)-poly(ε-caprolactone) iodinated nanocapsules as contrast agents for X-ray imaging.Pharm Res. 2013 Aug;30(8):2023-35. doi: 10.1007/s11095-013-1047-y. Epub 2013 Apr 26. Pharm Res. 2013. PMID: 23619594
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources